01:40Eli Lilly earnings topped estimates, so why the stock is sinking?
From the creator
Eli Lilly (LLY) shares slid at the open despite topping first quarter estimates, with investors reacting to the company lowering its full-year profit outlook. Investors are also reacting to a new deal between rival Novo Nordisk (NVO) and CVS (CVS) that could sideline Lilly's weight-loss drug Zepbound. Yahoo Finance Senior Reporter Anjalee Khemlani joins Morning Brief to break down what's weighing on Eli Lilly's stock. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here: https://finance.yahoo.com/videos/series/morning-brief/ #youtube #tariffs #stocks About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. - Get the latest news and data at finance.yahoo.com - Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO) - Follow Yahoo Finance on social: X: http://twitter.com/YahooFinance Instagram: https://www.instagram.com/yahoofinance/?hl=en TikTok: https://www.tiktok.com/@yahoofinance?lang=en Facebook: https://www.facebook.com/yahoofinance/ LinkedIn: https://www.linkedin.com/company/yahoo-finance
Published 2025-05-01 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.
Keep exploring News
01:40
01:38
12:22
04:50
32:27
02:54English village votes to leave UK over asylum accommodation plans | AJ #shorts
Al Jazeera English
01:45Croatia outraged after psychiatric patient dies from alleged hospital abuse | AJ #shorts
Al Jazeera English